PMID- 36848878 OWN - NLM STAT- MEDLINE DCOM- 20230605 LR - 20230821 IS - 1538-943X (Electronic) IS - 1058-2916 (Print) IS - 1058-2916 (Linking) VI - 69 IP - 6 DP - 2023 Jun 1 TI - Effect of Temperature on Thrombogenicity Testing of Biomaterials in an In Vitro Dynamic Flow Loop System. PG - 576-582 LID - 10.1097/MAT.0000000000001897 [doi] AB - To develop and standardize a reliable in vitro dynamic thrombogenicity test protocol, the key test parameters that could impact thrombus formation need to be investigated and understood. In this study, we evaluated the effect of temperature on the thrombogenic responses (thrombus surface coverage, thrombus weight, and platelet count reduction) of various materials using an in vitro blood flow loop test system. Whole blood from live sheep and cow donors was used to assess four materials with varying thrombogenic potentials: negative-control polytetrafluoroethylene (PTFE), positive-control latex, silicone, and high-density polyethylene (HDPE). Blood, heparinized to a donor-specific concentration, was recirculated through a polyvinyl chloride tubing loop containing the test material at room temperature (22-24 degrees C) for 1 hour, or at 37 degrees C for 1 or 2 hours. The flow loop system could effectively differentiate a thrombogenic material (latex) from the other materials for both test temperatures and blood species ( p < 0.05). However, compared with 37 degrees C, testing at room temperature appeared to have slightly better sensitivity in differentiating silicone (intermediate thrombogenic potential) from the relatively thromboresistant materials (PTFE and HDPE, p < 0.05). These data suggest that testing at room temperature may be a viable option for dynamic thrombogenicity assessment of biomaterials and medical devices. CI - Copyright (c) ASAIO 2023. FAU - Patel, Mehulkumar AU - Patel M AUID- ORCID: 0000-0002-0218-593 AD - From the Division of Applied Mechanics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration (FDA), Silver Spring, Maryland. FAU - Jamiolkowski, Megan A AU - Jamiolkowski MA AUID- ORCID: 0000-0002-5447-5621 FAU - Vejendla, Anjali AU - Vejendla A FAU - Bentley, Viviana AU - Bentley V FAU - Malinauskas, Richard A AU - Malinauskas RA AUID- ORCID: 0000-0002-5298-4502 FAU - Lu, Qijin AU - Lu Q AUID- ORCID: 0000-0002-3004-9433 LA - eng GR - FD999999/ImFDA/Intramural FDA HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. DEP - 20230227 PL - United States TA - ASAIO J JT - ASAIO journal (American Society for Artificial Internal Organs : 1992) JID - 9204109 RN - 0 (Biocompatible Materials) RN - 9002-88-4 (Polyethylene) RN - 0 (Latex) RN - 0 (Silicones) RN - 9002-84-0 (Polytetrafluoroethylene) SB - IM MH - Female MH - Cattle MH - Animals MH - Sheep MH - *Biocompatible Materials/adverse effects MH - Temperature MH - Polyethylene MH - Latex MH - *Thrombosis/etiology MH - Silicones MH - Polytetrafluoroethylene/adverse effects MH - Materials Testing PMC - PMC10368176 MID - NIHMS1916064 COIS- Disclosure: The authors have no conflicts of interest to report. EDAT- 2023/02/28 06:00 MHDA- 2023/06/05 06:42 PMCR- 2023/07/25 CRDT- 2023/02/27 18:47 PHST- 2023/06/05 06:42 [medline] PHST- 2023/02/28 06:00 [pubmed] PHST- 2023/02/27 18:47 [entrez] PHST- 2023/07/25 00:00 [pmc-release] AID - 00002480-202306000-00009 [pii] AID - 10.1097/MAT.0000000000001897 [doi] PST - ppublish SO - ASAIO J. 2023 Jun 1;69(6):576-582. doi: 10.1097/MAT.0000000000001897. Epub 2023 Feb 27.